In cancer research, the stakes are particularly high due to the potentially severe health consequences and the complexity of the disease. Adhering to ICH E6 guidelines ensures that the clinical trials are conducted in a manner that respects the rights and safety of participants while generating reliable data that can lead to effective new treatments. Moreover, adherence to these guidelines can facilitate faster regulatory approval and wider acceptance of new treatments globally.
